Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 22Multiple Myeloma 11Neoplasm Metastasis 9Pain 8Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Bone Neoplasms 5Osteoporosis 4Fractures, Bone 4Bone Diseases 4Lung Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Humoral Hypercalcemia Of Malignancy 2Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Pleural Effusion, Malignant 1Paraproteinemias 1Neoplastic Processes 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Neoplasms 1Hematologic Diseases 1Disease Progression 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 80Nivolumab 60Sunitinib 59Sorafenib 36Everolimus 32pazopanib 30Axitinib 27cabozantinib 25Ipilimumab 24Bevacizumab 24atezolizumab 20belzutifan 19lenvatinib 16avelumab 13Paclitaxel 10Docetaxel 9temsirolimus 8Cyclophosphamide 8spartalizumab 7fludarabine 7Interleukin-2 7Interferon alpha-2 7tivozanib 6durvalumab 6Cetuximab 6cemiplimab 5aldesleukin 5Ramucirumab 5CB-839 5bempegaldesleukin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Renal Cell × Zoledronic Acid × Clear all
NCT00172003 2016-11-18

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Novartis

Phase 4 Completed
50 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡